Neidig Brent 4

What Happened

• Brent Neidig, Chief Commercial Officer of USANA Health Sciences (USNA), sold 5,002 shares in an open-market sale on 2026-06-16. The weighted average sale price was $19.453, for total proceeds of $97,304.

Key Details

• Transaction date: 2026-06-16 (reported on Form 4 filed 2026-06-18).
• Price: Weighted average $19.453; price range across trades $19.35 to $19.68 (per footnote).
• Shares sold: 5,002; aggregate proceeds: $97,304.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 notes weighted average price and the price range.
• Timeliness: Filing dated 2026-06-18 for a 2026-06-16 transaction (appears to be filed within the two-business-day Form 4 reporting window).

Context

• This was a direct sale (transaction code S). Sales by executives can be routine (liquidity, diversification, tax obligations) and do not necessarily indicate a change in company outlook; no 10b5-1 plan, gift, or option exercise was reported in the provided details.